TF and cancer: It is notable that in controls the avidity of anti-TF IgG was very similar to that of anti-TF IgG in cancer patients, whereas the avidity of SNA-positive TF-specific antibodies in cancer patients was significantly higher compared with that of the other groups of patients and controls (Figure 4).